IFNA17 and COVID-19: This study significantly advances our understanding of COVID-19 severity by evaluating a comprehensive panel of cytokines and clinical markers, confirming the robust association between elevated levels of IL-1β, IL-6, IL-8, IL-10, IL-17A, IL-23, TNF-α, and IFN-α with critical disease outcomes.